Actively Recruiting

Phase Not Applicable
Age: 60Years +
All Genders
Healthy Volunteers
NCT07285226

Creatine HCl Supplementation in Sarcopenia: A Randomized Controlled Study

Led by Center for Health Sciences, Serbia · Updated on 2026-01-02

30

Participants Needed

1

Research Sites

41 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The CONCRET-SARCOPA trial is a 12-week, double-blind, randomized controlled study designed to evaluate the efficacy of creatine HCl supplementation in older adults with sarcopenia. The trial investigates whether daily creatine HCl improves body composition, enhances functional muscle and cognitive performance, and favorably alters key blood biomarkers associated with muscle health and metabolic status. Additionally, the study assesses changes in tissue creatine levels using non-invasive and biochemical methods to clarify mechanistic responses to supplementation. Findings from this trial will provide critical evidence on the therapeutic potential of creatine HCl as a targeted nutritional strategy for managing sarcopenia in the geriatric population.

CONDITIONS

Official Title

Creatine HCl Supplementation in Sarcopenia: A Randomized Controlled Study

Who Can Participate

Age: 60Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age > 60 years
  • Low muscle strength by handgrip (SDOC criteria for sarcopenia): < 35.5 kg in men and < 20 kg in women
  • Signed free and informed consent
  • Demonstrate interest, conditions and availability to participate
Not Eligible

You will not qualify if you...

  • Patients undergoing interventional treatment for sarcopenia
  • Physical amputation
  • Cognitive impairment (MSSE < 25)
  • Unwillingness to return for follow-up analysis
  • Participation in other clinical trials

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Center for Health Sciences

Belgrade, Serbia, 11000

Actively Recruiting

Loading map...

Research Team

S

Sergej Ostojic, MD, PhD

CONTACT

N

Nikola Todorovic

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Creatine HCl Supplementation in Sarcopenia: A Randomized Controlled Study | DecenTrialz